190 related articles for article (PubMed ID: 19083960)
1. Late enhancement on cardiac computed tomography in a patient with cardiac sarcoidosis.
Muth G; Daniel WG; Achenbach S
J Cardiovasc Comput Tomogr; 2008; 2(4):272-3. PubMed ID: 19083960
[TBL] [Abstract][Full Text] [Related]
2. Delayed contrast-enhanced computed tomography in patients with known or suspected cardiac sarcoidosis: A feasibility study.
Aikawa T; Oyama-Manabe N; Naya M; Ohira H; Sugimoto A; Tsujino I; Obara M; Manabe O; Kudo K; Tsutsui H; Tamaki N
Eur Radiol; 2017 Oct; 27(10):4054-4063. PubMed ID: 28382537
[TBL] [Abstract][Full Text] [Related]
3. Myocardial Extracellular Volume Fraction with Dual-Energy Equilibrium Contrast-enhanced Cardiac CT in Nonischemic Cardiomyopathy: A Prospective Comparison with Cardiac MR Imaging.
Lee HJ; Im DJ; Youn JC; Chang S; Suh YJ; Hong YJ; Kim YJ; Hur J; Choi BW
Radiology; 2016 Jul; 280(1):49-57. PubMed ID: 27322972
[TBL] [Abstract][Full Text] [Related]
4. Assessment of myocardial delayed enhancement with cardiac computed tomography in cardiomyopathies: a prospective comparison with delayed enhancement cardiac magnetic resonance imaging.
Lee HJ; Im DJ; Youn JC; Chang S; Suh YJ; Hong YJ; Kim YJ; Hur J; Choi BW
Int J Cardiovasc Imaging; 2017 Apr; 33(4):577-584. PubMed ID: 27873128
[TBL] [Abstract][Full Text] [Related]
5. Myocardial bridging: evaluation using single- and dual-source multidetector cardiac computed tomographic angiography.
Jacobs JE; Bod J; Kim DC; Hecht EM; Srichai MB
J Comput Assist Tomogr; 2008; 32(2):242-6. PubMed ID: 18379310
[TBL] [Abstract][Full Text] [Related]
6. Cardiac amyloidosis imaged by dual-source computed tomography.
Marwan M; Pflederer T; Ropers D; Schmid M; Wasmeier G; Söder S; Daniel WG; Achenbach S
J Cardiovasc Comput Tomogr; 2008 Nov; 2(6):403-5. PubMed ID: 19083986
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the myocardium with cardiac computed tomography.
Clayton B; Roobottom C; Morgan-Hughes G
Eur Heart J Cardiovasc Imaging; 2014 Jun; 15(6):603-9. PubMed ID: 24578413
[TBL] [Abstract][Full Text] [Related]
8. Optimization of contrast enhancement in thoracic MDCT.
Bae KT
Radiol Clin North Am; 2010 Jan; 48(1):9-29. PubMed ID: 19995627
[TBL] [Abstract][Full Text] [Related]
9. Myocardial hypoattenuation in cardiac sarcoidosis: CT correlation with CMR, PET and SPECT.
Raimondi PM; Lisker J; Rini JN; Vitkovski T; Rahmani N; Kuvin JT; Saba SG
Clin Imaging; 2020 Nov; 67():136-142. PubMed ID: 32622334
[TBL] [Abstract][Full Text] [Related]
10. Cardiac sarcoidosis evaluated with gadolinium-enhanced magnetic resonance and contrast-enhanced 64-slice computed tomography.
Smedema JP; Truter R; de Klerk PA; Zaaiman L; White L; Doubell AF
Int J Cardiol; 2006 Sep; 112(2):261-3. PubMed ID: 16257460
[TBL] [Abstract][Full Text] [Related]
11. CT angiography: injection and acquisition technique.
Fleischmann D
Radiol Clin North Am; 2010 Mar; 48(2):237-47, vii. PubMed ID: 20609872
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography contrast enhancement principles and the use of high-concentration contrast media.
Herman S
J Comput Assist Tomogr; 2004; 28 Suppl 1():S7-11. PubMed ID: 15258487
[TBL] [Abstract][Full Text] [Related]
13. Texture analysis of delayed contrast-enhanced computed tomography to diagnose cardiac sarcoidosis.
Tsuneta S; Oyama-Manabe N; Hirata K; Harada T; Aikawa T; Manabe O; Ohira H; Koyanagawa K; Naya M; Kudo K
Jpn J Radiol; 2021 May; 39(5):442-450. PubMed ID: 33483941
[TBL] [Abstract][Full Text] [Related]
14. Review: Contrast-enhanced magnetic resonance in the diagnosis and management of cardiac sarcoidosis.
Smedema JP; Ainslie G; Crijns HJGM
Prog Cardiovasc Dis; 2020; 63(3):271-307. PubMed ID: 32330463
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of cardiac involvement of sarcoidosis by contrast-enhanced multislice computed tomography and delayed-enhanced magnetic resonance imaging.
Kanao S; Tadamura E; Yamamuro M; Kubo S; Kimura T; Kita T; Togashi K
J Comput Assist Tomogr; 2005; 29(6):745-8. PubMed ID: 16272844
[TBL] [Abstract][Full Text] [Related]
16. The use of a flow rate injector for contrast-enhanced computed tomography.
McCarthy S; Moss AA
Radiology; 1984 Jun; 151(3):800. PubMed ID: 6718744
[TBL] [Abstract][Full Text] [Related]
17. [Thoracic sarcoidosis].
Herráez Ortega I; López González L
Radiologia; 2011; 53(5):434-48. PubMed ID: 21937066
[TBL] [Abstract][Full Text] [Related]
18. Optimal vascular and parenchymal contrast enhancement: the current state of the art.
Fleischmann D; Kamaya A
Radiol Clin North Am; 2009 Jan; 47(1):13-26. PubMed ID: 19195531
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
[TBL] [Abstract][Full Text] [Related]
20. Current role of cardiac computed tomography.
Achenbach S; Daniel WG
Herz; 2007 Mar; 32(2):97-107. PubMed ID: 17401752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
